These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6497571)

  • 21. Depression dexamethasone nonsuppression and negative symptoms in schizophrenia.
    Addington D; Addington J
    Can J Psychiatry; 1990 Jun; 35(5):430-3. PubMed ID: 2372754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The dexamethasone suppression test in relation to symptomatology: preliminary findings controlling for serum dexamethasone concentrations.
    Smith J; Carr V; Morris H; Gilliland J
    Psychiatry Res; 1988 Aug; 25(2):123-33. PubMed ID: 3174902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dissociation between pituitary and adrenal suppression to dexamethasone in depression.
    Young EA; Kotun J; Haskett RF; Grunhaus L; Greden JF; Watson SJ; Akil H
    Arch Gen Psychiatry; 1993 May; 50(5):395-403. PubMed ID: 8489328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cortisol and Alzheimer's disease, II: Dexamethasone suppression, dementia severity, and affective symptoms.
    Greenwald BS; Mathé AA; Mohs RC; Levy MI; Johns CA; Davis KL
    Am J Psychiatry; 1986 Apr; 143(4):442-6. PubMed ID: 3953887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The dexamethasone suppression test in schizophrenia.
    Sawyer J; Jeffries JJ
    J Clin Psychiatry; 1984 Sep; 45(9):399-402. PubMed ID: 6469927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A longitudinal evaluation of dexamethasone and cortisol plasma concentrations in the dexamethasone suppression test before and during treatment with antidepressant drugs.
    Guthrie SK; Vartanian L; Grunhaus L; Hariharan M; Pande A; Haskett RF
    Acta Psychiatr Scand; 1990 Dec; 82(6):427-32. PubMed ID: 2291411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of glycemic control on the overnight dexamethasone suppression test in patients with diabetes mellitus.
    Kaye TB; Rubin RA; Goldfine AB; Rajamani K; Kinsley BT; Vischer UM; Simonson DC
    J Clin Endocrinol Metab; 1992 Mar; 74(3):640-4. PubMed ID: 1740499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The limited utility of the dexamethasone suppression test for the diagnostic process in psychiatry.
    Berger M; Pirke KM; Doerr P; Krieg JC; von Zerssen D
    Br J Psychiatry; 1984 Oct; 145():372-82. PubMed ID: 6487910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dexamethasone suppression test in recently detoxified alcoholics: clinical implications.
    Khan A; Ciraulo DA; Nelson WH; Becker JT; Nies A; Jaffe JH
    J Clin Psychopharmacol; 1984 Apr; 4(2):94-7. PubMed ID: 6707246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic caffeine consumption and the dexamethasone suppression test in depression.
    Lee MA; Flegel P; Cameron OG; Greden JF
    Psychiatry Res; 1988 Apr; 24(1):61-5. PubMed ID: 3393618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The dexamethasone suppression test in residual schizophrenia with depression.
    Munro JG; Hardiker TM; Leonard DP
    Am J Psychiatry; 1984 Feb; 141(2):250-2. PubMed ID: 6691488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DST studies in psychotic depression: a meta-analysis.
    Nelson JC; Davis JM
    Am J Psychiatry; 1997 Nov; 154(11):1497-503. PubMed ID: 9356556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depression, negative and positive symptoms, and the DST in schizophrenia.
    Minas IH; Jackson HJ; Joshua SD; Burgess PM
    Schizophr Res; 1990; 3(5-6):321-7. PubMed ID: 2282337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dexamethasone suppression test and TRH test in endogenous depression.
    Aggernaes H; Kirkegaard C; Krog-Meyer I; Kijne B; Larsen JK; Laursen AL; Lykke-Olesen L; Mikkelsen PL; Rasmussen S; Bjørum N
    Acta Psychiatr Scand; 1983 Apr; 67(4):258-64. PubMed ID: 6407280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The dexamethasone suppression index: enhancement of DST diagnostic utility for depression by expressing serum cortisol as a function of serum dexamethasone.
    Arana GW; Reichlin S; Workman R; Haaser R; Shader RI
    Am J Psychiatry; 1988 Jun; 145(6):707-11. PubMed ID: 3369557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The dexamethasone suppression test in adolescent psychiatric inpatients.
    Targum SD; Capodanno AE
    Am J Psychiatry; 1983 May; 140(5):589-91. PubMed ID: 6846588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma dexamethasone levels in children given the dexamethasone suppression test.
    Naylor MW; Greden JF; Alessi NE
    Biol Psychiatry; 1990 Mar; 27(6):592-600. PubMed ID: 2322618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The dexamethasone suppression test in a group of research diagnostic criteria schizoaffective depressed men.
    Wahby VS; Ibrahim GA; Giller EL; Saddik FW; Mason JW; Adams JR
    Neuropsychobiology; 1990-1991; 23(3):129-33. PubMed ID: 2098669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Low-dose (0.5 mg) DST in manic and major depressive episodes: in relation to the severity of symptoms].
    Matsunaga H; Sarai M
    Seishin Shinkeigaku Zasshi; 2000; 102(4):367-98. PubMed ID: 10892305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamics of the cortisol suppression index in depression.
    Bernstein JP; Chung SY
    J Clin Psychiatry; 1984 Oct; 45(10):433-6. PubMed ID: 6480569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.